Literature DB >> 18694995

Diarctigenin, a lignan constituent from Arctium lappa, down-regulated zymosan-induced transcription of inflammatory genes through suppression of DNA binding ability of nuclear factor-kappaB in macrophages.

Byung Hak Kim1, Seong Su Hong, Soon Woo Kwon, Hwa Young Lee, Hyeran Sung, In-Jeong Lee, Bang Yeon Hwang, Sukgil Song, Chong-Kil Lee, Daehyun Chung, Byeongwoo Ahn, Sang-Yoon Nam, Sang-Bae Han, Youngsoo Kim.   

Abstract

Diarctigenin was previously isolated as an inhibitor of nitric oxide (NO) production in macrophages from the seeds of Arctium lappa used as an alternative medicine for the treatment of inflammatory disorders. However, little is known about the molecular basis of these effects. Here, we demonstrated that diarctigenin inhibited the production of NO, prostaglandin E(2), tumor necrosis factor-alpha, and interleukin (IL)-1beta and IL-6 with IC(50) values of 6 to 12 miciroM in zymosan- or lipopolysaccharide-(LPS) activated macrophages. Diarctigenin attenuated zymosan-induced mRNA synthesis of inducible NO synthase (iNOS) and also inhibited promoter activities of iNOS and cytokine genes in the cells. Because nuclear factor (NF)-kappaB plays a pivotal role in inflammatory gene transcription, we next investigated the effect of diarctigenin on NF-kappaB activation. Diarctigenin inhibited the transcriptional activity and DNA binding ability of NF-kappaB in zymosan-activated macrophages but did not affect the degradation and phosphorylation of inhibitory kappaB (IkappaB) proteins. Moreover, diarctigenin suppressed expression vector NF-kappaB p65-elicited NF-kappaB activation and also iNOS promoter activity, indicating that the compound could directly target an NF-kappa-activating signal cascade downstream of IkappaB degradation and inhibit NF-kappaB-regulated iNOS expression. Diarctigenin also inhibited the in vitro DNA binding ability of NF-kappaB but did not affect the nuclear import of NF-kappaB p65 in the cells. Taken together, diarctigenin down-regulated zymosan- or LPS-induced inflammatory gene transcription in macrophages, which was due to direct inhibition of the DNA binding ability of NF-kappaB. Finally, this study provides a pharmacological potential of diarctigenin in the NF-kappaB-associated inflammatory disorders.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18694995     DOI: 10.1124/jpet.108.140145

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  7 in total

Review 1.  A review of the pharmacological effects of Arctium lappa (burdock).

Authors:  Yuk-Shing Chan; Long-Ni Cheng; Jian-Hong Wu; Enoch Chan; Yiu-Wa Kwan; Simon Ming-Yuen Lee; George Pak-Heng Leung; Peter Hoi-Fu Yu; Shun-Wan Chan
Journal:  Inflammopharmacology       Date:  2010-10-28       Impact factor: 4.473

2.  A cell-penetrating peptide suppresses inflammation by inhibiting NF-κB signaling.

Authors:  Yu Fu Wang; Xiang Xu; Xia Fan; Chun Zhang; Qiang Wei; Xi Wang; Wei Guo; Wei Xing; Jian Yu; Jing-Long Yan; Hua-Ping Liang
Journal:  Mol Ther       Date:  2011-05-10       Impact factor: 11.454

3.  A leaf methanolic extract of Wercklea insignis attenuates the lipopolysaccharide-induced inflammatory response by blocking the NF-κB signaling pathway in RAW 264.7 macrophages.

Authors:  Ji-Won Park; Ok-Kyoung Kwon; Ha-young Jang; Hyeok Jeong; Sei-Ryang Oh; Hyeong-Kyu Lee; Sang-Bae Han; Kyung-Seop Ahn
Journal:  Inflammation       Date:  2012-02       Impact factor: 4.092

4.  Inhibition of nitric oxide production in lipopolysaccharide-activated RAW 264.7 macrophages by Jeju plant extracts.

Authors:  Eun-Jin Yang; Eun-Young Yim; Gwanpil Song; Gi-Ok Kim; Chang-Gu Hyun
Journal:  Interdiscip Toxicol       Date:  2009-12-28

5.  Arctium lappa Root Extract Prevents Lead-Induced Liver Injury by Attenuating Oxidative Stress and Inflammation, and Activating Akt/GSK-3β Signaling.

Authors:  Ahlam Alhusaini; Laila Fadda; Iman H Hasan; Hanaa M Ali; Naglaa F El Orabi; Amira M Badr; Enas Zakaria; Abeer M Alenazi; Ayman M Mahmoud
Journal:  Antioxidants (Basel)       Date:  2019-11-24

6.  Anesthetic isoflurane posttreatment attenuates experimental lung injury by inhibiting inflammation and apoptosis.

Authors:  Jun-tang Li; Hui Wang; Wei Li; Li-feng Wang; Li-chao Hou; Jing-lan Mu; Xin Liu; Hui-juan Chen; Ke-lang Xie; Nan-lin Li; Chun-fang Gao
Journal:  Mediators Inflamm       Date:  2013-04-17       Impact factor: 4.711

7.  A subanesthetic dose of isoflurane during postconditioning ameliorates zymosan-induced neutrophil inflammation lung injury and mortality in mice.

Authors:  Hui Wang; Jing Fan; Nan-lin Li; Jun-tang Li; Shi-fang Yuan; Jun Yi; Ling Wang; Jiang-hao Chen; Yong-gang Lv; Qing Yao; Ting Wang; Yu-cai Wang; Rui Ling
Journal:  Mediators Inflamm       Date:  2013-11-27       Impact factor: 4.711

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.